Symbols / CDT Stock $2.96 -4.05% CDT Equity Inc.
CDT (Stock) Chart
About
CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has strategic services agreement with formulation development CDMO Agility Life Sciences to develop new solid oral-dosage form products. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.
Stock Fundamentals
Scroll to Statements| Market Cap | 14.38M | Enterprise Value | 14.47M | Income | -39.22M | Sales | — | Book/sh | -77.82 | Cash/sh | 0.31 |
| Dividend Yield | — | Payout | 0.00% | Employees | — | IPO | — | P/E | — | Forward P/E | — |
| PEG | — | P/S | — | P/B | -0.04 | P/C | — | EV/EBITDA | -0.42 | EV/Sales | — |
| Quick Ratio | 0.12 | Current Ratio | 0.34 | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | -1177.89 | EPS next Y | — |
| EPS Growth | — | Revenue Growth | — | Earnings | 2025-11-12 | ROA | -4.67% | ROE | — | ROIC | — |
| Gross Margin | 0.00% | Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 4.86M | Shs Float | 2.78M | Short Float | 1.97% |
| Short Ratio | 1.40 | Short Interest | — | 52W High | 1755.00 | 52W Low | 2.60 | Beta | 2.08 | Avg Volume | 86.66K |
| Volume | 37.02K | Target Price | — | Recom | None | Prev Close | $3.08 | Price | $2.96 | Change | -4.05% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$2.96
Latest analyst target
3. DCF / Fair value
$-2.87
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.96
Low
—
High
—
Mean
—
News
RSS: Latest CDT news- CDT Equity (NASDAQ: CDT) registers 5.35M shares; ELOC and Sarborg issuances - Stock Titan Wed, 22 Apr 2026 10
- CDT Equity - Files For Offering Of Up To 5.35 Million Shares Of Common Stock - SEC Filing - TradingView Wed, 22 Apr 2026 10
- CDT Equity Inc. Announces Reverse Stock Split - Yahoo Finance Wed, 25 Mar 2026 07
- Equity Inc (CDT) Stock: Is It Reasonably Valued (Dips) 2026-04-20 - Elite Trading Signals - Xã Thanh Hà Mon, 20 Apr 2026 22
- CDT Equity - files for offering of up to 5.35 million shares of common stock - SEC filing - marketscreener.com Wed, 22 Apr 2026 11
- CDT Equity stock tumbles after $115M Sarborg stake deal - Investing.com Fri, 20 Feb 2026 08
- CDT Stock Dips as Financial Challenges Mount Amid Market Shifts - timothysykes.com Fri, 20 Feb 2026 08
- CDT Equity Announces 1-for-25 Reverse Stock Split - The Globe and Mail hu, 26 Mar 2026 07
- CDT shrinks share count to about 4.7M in 1-for-25 reverse split - Stock Titan Wed, 25 Mar 2026 07
- Working capital per share of CDT Equity Inc. – FWB:ZK7 - TradingView Wed, 22 Apr 2026 16
- CDT Equity approves 1-for-25 reverse stock split effective Thursday - Investing.com Wed, 25 Mar 2026 07
- Tiny Nasdaq biotech links AstraZeneca assets with AI drug hunting - Stock Titan hu, 16 Apr 2026 12
- Sarborg takes its signature-mapping platform from drug research to crops - Stock Titan ue, 07 Apr 2026 07
- CDT Equity (CDT) discloses pre-funded warrants from Sarborg deal - Stock Titan Mon, 30 Mar 2026 07
- Psoriasis drug tapinarof gets 2 new patent filings as CDT targets licensing - Stock Titan hu, 26 Mar 2026 07
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
36.66
+142.70%
|
15.11
+187.06%
|
5.26
+66.52%
|
3.16
|
| Research And Development |
|
5.05
+49.62%
|
3.38
+3653.33%
|
0.09
-18.92%
|
0.11
|
| Selling General And Administration |
|
31.70
+163.29%
|
12.04
+132.81%
|
5.17
+69.63%
|
3.05
|
| General And Administrative Expense |
|
31.70
+163.29%
|
12.04
+132.81%
|
5.17
+69.63%
|
3.05
|
| Other Gand A |
|
31.70
+163.29%
|
12.04
+132.81%
|
5.17
+69.63%
|
3.05
|
| Total Expenses |
|
36.66
+142.70%
|
15.11
+187.06%
|
5.26
+66.52%
|
3.16
|
| Operating Income |
|
-36.66
-142.70%
|
-15.11
-187.06%
|
-5.26
-66.52%
|
-3.16
|
| Total Operating Income As Reported |
|
-36.76
-138.39%
|
-15.42
-193.03%
|
-5.26
-66.52%
|
-3.16
|
| EBITDA |
|
-36.48
-130.32%
|
-15.84
-618.80%
|
3.05
+162.47%
|
-4.89
|
| Normalized EBITDA |
|
-36.88
-140.42%
|
-15.34
-298.75%
|
-3.85
-12.32%
|
-3.42
|
| Reconciled Depreciation |
|
2.42
+430.63%
|
0.46
|
0.00
|
—
|
| EBIT |
|
-38.91
-138.74%
|
-16.30
-633.77%
|
3.05
+162.47%
|
-4.89
|
| Total Unusual Items |
|
0.40
+180.16%
|
-0.50
-107.23%
|
6.90
+571.96%
|
-1.46
|
| Total Unusual Items Excluding Goodwill |
|
0.40
+180.16%
|
-0.50
-107.23%
|
6.90
+571.96%
|
-1.46
|
| Special Income Charges |
|
0.25
+134.84%
|
-0.71
|
—
|
—
|
| Other Special Charges |
|
-0.65
-191.93%
|
0.71
|
—
|
—
|
| Net Income |
|
-39.22
-120.33%
|
-17.80
-3227.48%
|
-0.54
+89.05%
|
-4.89
|
| Pretax Income |
|
-39.22
-120.33%
|
-17.80
-726.39%
|
2.84
+158.15%
|
-4.89
|
| Net Non Operating Interest Income Expense |
|
-0.29
+80.51%
|
-1.49
-661.73%
|
-0.20
|
0.00
|
| Interest Expense Non Operating |
|
0.32
-78.82%
|
1.51
+613.74%
|
0.21
|
0.00
|
| Net Interest Income |
|
-0.29
+80.51%
|
-1.49
-661.73%
|
-0.20
|
0.00
|
| Interest Expense |
|
0.32
-78.82%
|
1.51
+613.74%
|
0.21
|
0.00
|
| Interest Income Non Operating |
|
0.03
+115.38%
|
0.01
-13.33%
|
0.01
|
0.00
|
| Interest Income |
|
0.03
+115.38%
|
0.01
-13.33%
|
0.01
|
0.00
|
| Other Income Expense |
|
-2.27
-88.79%
|
-1.20
-114.51%
|
8.30
+580.60%
|
-1.73
|
| Other Non Operating Income Expenses |
|
-2.67
-279.15%
|
-0.70
-150.36%
|
1.40
+628.30%
|
-0.27
|
| Gain On Sale Of Security |
|
0.15
-25.60%
|
0.21
-97.00%
|
6.90
+571.96%
|
-1.46
|
| Tax Rate For Calcs |
|
0.00
|
0.00
-100.00%
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
-100.00%
|
1.45
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-39.22
-120.33%
|
-17.80
-726.39%
|
2.84
+158.15%
|
-4.89
|
| Net Income From Continuing Operation Net Minority Interest |
|
-39.22
-120.33%
|
-17.80
-3227.48%
|
-0.54
+89.05%
|
-4.89
|
| Net Income From Continuing And Discontinued Operation |
|
-39.22
-120.33%
|
-17.80
-3227.48%
|
-0.54
+89.05%
|
-4.89
|
| Net Income Continuous Operations |
|
-39.22
-120.33%
|
-17.80
-726.39%
|
2.84
+158.15%
|
-4.89
|
| Normalized Income |
|
-39.62
-129.00%
|
-17.30
-189.06%
|
-5.99
-74.77%
|
-3.42
|
| Net Income Common Stockholders |
|
-39.22
-120.33%
|
-17.80
-3227.48%
|
-0.54
+89.05%
|
-4.89
|
| Diluted EPS |
|
-1,177.89
+96.95%
|
-38,616.05
-56.86%
|
-24,617.89
-21.40%
|
-20,278.01
|
| Basic EPS |
|
-1,177.89
+96.95%
|
-38,616.05
-1675.62%
|
-2,174.80
+89.28%
|
-20,278.01
|
| Basic Average Shares |
|
0.03
+7123.43%
|
0.00
+87.40%
|
0.00
+2.07%
|
0.00
|
| Diluted Average Shares |
|
0.03
+7123.43%
|
0.00
+87.40%
|
0.00
+2.07%
|
0.00
|
| Diluted NI Availto Com Stockholders |
|
-39.22
-120.33%
|
-17.80
-193.96%
|
-6.06
-23.92%
|
-4.89
|
| Average Dilution Earnings |
|
—
|
0.00
+100.00%
|
-5.52
|
—
|
| Gain On Sale Of PPE |
|
-0.40
|
0.00
|
—
|
—
|
| Other Taxes |
|
-0.10
+69.11%
|
-0.31
|
—
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
5.65
+34.75%
|
4.19
-41.96%
|
7.22
+144380.00%
|
0.01
|
| Current Assets |
|
4.38
+61.29%
|
2.71
-52.64%
|
5.73
|
0.00
|
| Cash Cash Equivalents And Short Term Investments |
|
1.51
+172.38%
|
0.55
-86.90%
|
4.23
|
0.00
|
| Cash And Cash Equivalents |
|
1.51
+172.38%
|
0.55
-86.90%
|
4.23
|
0.00
|
| Receivables |
|
—
|
0.49
|
0.00
|
—
|
| Other Receivables |
|
—
|
0.49
|
—
|
—
|
| Prepaid Assets |
|
1.05
+175.53%
|
0.38
-74.75%
|
1.50
|
0.00
|
| Other Current Assets |
|
1.82
+2.36%
|
1.78
|
—
|
—
|
| Total Non Current Assets |
|
1.27
-14.01%
|
1.48
-0.87%
|
1.49
+29720.00%
|
0.01
|
| Net PPE |
|
0.41
+35.64%
|
0.30
|
0.00
|
—
|
| Gross PPE |
|
0.41
+35.64%
|
0.30
|
0.00
|
—
|
| Other Properties |
|
0.41
+35.64%
|
0.30
|
—
|
—
|
| Goodwill And Other Intangible Assets |
|
—
|
—
|
0.00
-100.00%
|
0.01
|
| Other Intangible Assets |
|
—
|
—
|
—
|
0.01
|
| Other Non Current Assets |
|
0.86
-26.81%
|
1.18
-21.19%
|
1.49
|
—
|
| Total Liabilities Net Minority Interest |
|
12.82
+16.69%
|
10.99
+43.03%
|
7.68
-23.91%
|
10.09
|
| Current Liabilities |
|
12.82
+19.36%
|
10.74
+496.39%
|
1.80
-56.87%
|
4.18
|
| Payables And Accrued Expenses |
|
12.04
+255.20%
|
3.39
+315.56%
|
0.82
-68.42%
|
2.58
|
| Payables |
|
1.91
+33.96%
|
1.43
+564.19%
|
0.21
|
—
|
| Accounts Payable |
|
1.91
+33.96%
|
1.43
+564.19%
|
0.21
|
0.00
|
| Current Accrued Expenses |
|
10.13
+416.15%
|
1.96
+226.62%
|
0.60
-76.74%
|
2.58
|
| Current Debt And Capital Lease Obligation |
|
0.78
-89.46%
|
7.35
+646.19%
|
0.98
+462.86%
|
0.17
|
| Current Debt |
|
0.66
-90.87%
|
7.23
+634.11%
|
0.98
+462.86%
|
0.17
|
| Other Current Borrowings |
|
0.66
-90.08%
|
6.66
+732.00%
|
0.80
+357.14%
|
0.17
|
| Current Capital Lease Obligation |
|
0.12
-3.36%
|
0.12
|
0.00
|
—
|
| Other Current Liabilities |
|
—
|
—
|
—
|
1.42
|
| Total Non Current Liabilities Net Minority Interest |
|
0.00
-100.00%
|
0.24
-95.83%
|
5.88
-0.64%
|
5.92
|
| Long Term Debt And Capital Lease Obligation |
|
0.00
-100.00%
|
0.11
|
0.00
-100.00%
|
1.83
|
| Long Term Debt |
|
—
|
—
|
—
|
1.83
|
| Long Term Capital Lease Obligation |
|
0.00
-100.00%
|
0.11
|
0.00
|
—
|
| Tradeand Other Payables Non Current |
|
—
|
0.00
-100.00%
|
5.74
|
0.00
|
| Non Current Deferred Liabilities |
|
—
|
—
|
0.00
-100.00%
|
4.08
|
| Non Current Deferred Revenue |
|
—
|
—
|
0.00
-100.00%
|
4.08
|
| Stockholders Equity |
|
-7.17
-5.55%
|
-6.79
-1386.43%
|
-0.46
+95.47%
|
-10.09
|
| Common Stock Equity |
|
-7.17
-5.55%
|
-6.79
-1386.43%
|
-0.46
+95.47%
|
-10.09
|
| Capital Stock |
|
0.00
|
0.00
-100.00%
|
0.01
+16.67%
|
0.01
|
| Common Stock |
|
0.00
|
0.00
-100.00%
|
0.01
+16.67%
|
0.01
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
0.09
+19886.98%
|
0.00
+87.40%
|
0.00
+2.07%
|
0.00
|
| Ordinary Shares Number |
|
0.09
+19886.98%
|
0.00
+87.40%
|
0.00
+2.07%
|
0.00
|
| Additional Paid In Capital |
|
61.17
+179.40%
|
21.89
+110.03%
|
10.42
|
0.00
|
| Retained Earnings |
|
-68.33
-134.79%
|
-29.10
-157.55%
|
-11.30
-4.91%
|
-10.77
|
| Gains Losses Not Affecting Retained Earnings |
|
-0.02
-103.86%
|
0.41
+0.73%
|
0.41
-39.11%
|
0.68
|
| Other Equity Adjustments |
|
-0.02
-103.86%
|
0.41
+0.73%
|
0.41
-39.11%
|
0.68
|
| Total Equity Gross Minority Interest |
|
-7.17
-5.55%
|
-6.79
-1386.43%
|
-0.46
+95.47%
|
-10.09
|
| Total Capitalization |
|
-7.17
-5.55%
|
-6.79
-1386.43%
|
-0.46
+94.46%
|
-8.25
|
| Working Capital |
|
-8.44
-5.17%
|
-8.03
-304.12%
|
3.93
+194.16%
|
-4.18
|
| Invested Capital |
|
-6.51
-1586.30%
|
0.44
-17.05%
|
0.53
+106.54%
|
-8.08
|
| Total Debt |
|
0.78
-89.61%
|
7.46
+657.06%
|
0.98
-51.00%
|
2.01
|
| Net Debt |
|
—
|
6.68
|
—
|
2.01
|
| Capital Lease Obligations |
|
0.12
-49.12%
|
0.23
|
0.00
|
—
|
| Net Tangible Assets |
|
-7.17
-5.55%
|
-6.79
-1386.43%
|
-0.46
+95.47%
|
-10.09
|
| Tangible Book Value |
|
-7.17
-5.55%
|
-6.79
-1386.43%
|
-0.46
+95.47%
|
-10.09
|
| Current Notes Payable |
|
0.00
-100.00%
|
0.57
+210.81%
|
0.18
|
—
|
| Derivative Product Liabilities |
|
0.00
-100.00%
|
0.14
-2.82%
|
0.14
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-15.55
-60.66%
|
-9.68
-25.33%
|
-7.72
-240.91%
|
-2.27
|
| Cash Flow From Continuing Operating Activities |
|
-15.55
-60.66%
|
-9.68
-25.33%
|
-7.72
-240.91%
|
-2.27
|
| Net Income From Continuing Operations |
|
-39.22
-120.33%
|
-17.80
-3227.48%
|
-0.54
+89.05%
|
-4.89
|
| Depreciation Amortization Depletion |
|
2.42
+430.63%
|
0.46
|
0.00
|
—
|
| Depreciation |
|
0.02
+110.00%
|
0.01
|
0.00
|
—
|
| Amortization Cash Flow |
|
2.40
+437.81%
|
0.45
|
0.00
|
—
|
| Depreciation And Amortization |
|
2.42
+430.63%
|
0.46
|
0.00
|
—
|
| Amortization Of Intangibles |
|
2.40
+437.81%
|
0.45
|
0.00
|
—
|
| Other Non Cash Items |
|
14.36
+383.28%
|
2.97
+199.60%
|
0.99
+274.34%
|
0.27
|
| Stock Based Compensation |
|
2.18
+33.76%
|
1.63
+720.10%
|
0.20
|
0.00
|
| Provisionand Write Offof Assets |
|
—
|
0.00
+100.00%
|
-0.24
-172.51%
|
0.33
|
| Operating Gains Losses |
|
-0.03
-100.91%
|
3.20
+156.91%
|
-5.62
-493.63%
|
1.43
|
| Gain Loss On Investment Securities |
|
0.27
-89.32%
|
2.48
+144.32%
|
-5.60
-491.74%
|
1.43
|
| Net Foreign Currency Exchange Gain Loss |
|
-0.02
-223.08%
|
0.01
+133.33%
|
-0.04
|
0.00
|
| Change In Working Capital |
|
4.73
+3428.87%
|
-0.14
+94.36%
|
-2.52
-522.15%
|
0.60
|
| Change In Prepaid Assets |
|
-4.06
-78.71%
|
-2.27
-129.60%
|
-0.99
|
0.00
|
| Change In Payables And Accrued Expense |
|
-0.68
-130.16%
|
2.25
+247.29%
|
-1.53
-354.74%
|
0.60
|
| Change In Accrued Expense |
|
-1.11
-208.16%
|
1.03
+158.99%
|
-1.75
-390.52%
|
0.60
|
| Change In Payable |
|
0.43
-64.57%
|
1.23
+469.77%
|
0.21
|
—
|
| Change In Account Payable |
|
0.43
-64.57%
|
1.23
+469.77%
|
0.21
|
0.00
|
| Change In Other Working Capital |
|
—
|
—
|
—
|
0.33
|
| Change In Other Current Assets |
|
—
|
0.00
-100.00%
|
0.01
+200.00%
|
-0.01
|
| Change In Other Current Liabilities |
|
9.47
+7736.29%
|
-0.12
|
0.00
|
—
|
| Investing Cash Flow |
|
-0.81
-1779.07%
|
-0.04
-105.93%
|
0.72
+496.17%
|
-0.18
|
| Cash Flow From Continuing Investing Activities |
|
-0.81
-1779.07%
|
-0.04
-105.93%
|
0.72
+496.17%
|
-0.18
|
| Net PPE Purchase And Sale |
|
-0.41
-694.12%
|
-0.05
|
0.00
|
—
|
| Purchase Of PPE |
|
-0.41
-694.12%
|
-0.05
|
0.00
|
—
|
| Capital Expenditure |
|
-2.40
-4611.76%
|
-0.05
|
—
|
—
|
| Net Investment Purchase And Sale |
|
0.00
-100.00%
|
0.01
-98.39%
|
0.50
+235.81%
|
0.15
|
| Purchase Of Investment |
|
0.00
+100.00%
|
-0.49
|
0.00
|
—
|
| Sale Of Investment |
|
0.00
-100.00%
|
0.50
+0.20%
|
0.50
+235.81%
|
0.15
|
| Net Intangibles Purchase And Sale |
|
-0.40
|
0.00
|
—
|
—
|
| Purchase Of Intangibles |
|
-2.00
|
0.00
|
—
|
—
|
| Net Other Investing Changes |
|
—
|
—
|
0.23
+168.88%
|
-0.33
|
| Financing Cash Flow |
|
17.42
+187.16%
|
6.07
-44.49%
|
10.93
+346.45%
|
2.45
|
| Cash Flow From Continuing Financing Activities |
|
17.42
+187.16%
|
6.07
-44.49%
|
10.93
+346.45%
|
2.45
|
| Net Issuance Payments Of Debt |
|
-2.17
-188.61%
|
2.45
+7.17%
|
2.29
+106.50%
|
1.11
|
| Issuance Of Debt |
|
0.00
-100.00%
|
3.23
+41.12%
|
2.29
+106.50%
|
1.11
|
| Repayment Of Debt |
|
-2.17
-179.77%
|
-0.78
|
0.00
|
—
|
| Long Term Debt Issuance |
|
—
|
—
|
2.29
+106.50%
|
1.11
|
| Net Long Term Debt Issuance |
|
—
|
—
|
2.29
+106.50%
|
1.11
|
| Short Term Debt Issuance |
|
0.00
-100.00%
|
3.23
+41.12%
|
2.29
|
—
|
| Short Term Debt Payments |
|
-2.17
-179.77%
|
-0.78
|
0.00
|
—
|
| Net Short Term Debt Issuance |
|
-2.17
-188.61%
|
2.45
+7.17%
|
2.29
|
—
|
| Net Common Stock Issuance |
|
19.59
+488.73%
|
3.33
|
0.00
-100.00%
|
1.34
|
| Common Stock Payments |
|
-0.11
|
0.00
|
—
|
—
|
| Repurchase Of Capital Stock |
|
-0.11
|
0.00
|
—
|
—
|
| Proceeds From Stock Option Exercised |
|
0.00
-100.00%
|
0.29
|
0.00
|
—
|
| Net Other Financing Charges |
|
—
|
—
|
8.64
|
—
|
| Changes In Cash |
|
1.06
+128.95%
|
-3.66
-193.10%
|
3.93
+393000.00%
|
-0.00
|
| Effect Of Exchange Rate Changes |
|
-0.10
-550.00%
|
-0.02
-105.35%
|
0.30
+29800.00%
|
0.00
|
| Beginning Cash Position |
|
0.55
-86.90%
|
4.23
|
0.00
|
0.00
|
| End Cash Position |
|
1.51
+172.38%
|
0.55
-86.90%
|
4.23
|
0.00
|
| Free Cash Flow |
|
-17.96
-84.51%
|
-9.73
-25.99%
|
-7.72
-240.91%
|
-2.27
|
| Interest Paid Supplemental Data |
|
0.00
-100.00%
|
0.08
-35.48%
|
0.12
|
0.00
|
| Common Stock Issuance |
|
19.70
+491.92%
|
3.33
|
0.00
-100.00%
|
1.34
|
| Issuance Of Capital Stock |
|
19.70
+491.92%
|
3.33
|
0.00
-100.00%
|
1.34
|
| Sale Of Intangibles |
|
1.59
|
0.00
|
—
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 10-K2026-04-15 View
- 42026-03-30 View
- 8-K2026-03-25 View
- 8-K2026-03-18 View
- 8-K2026-03-09 View
- 8-K2026-02-24 View
- 42026-02-23 View
- 8-K2026-01-22 View
- 8-K2026-01-02 View
- 42025-12-22 View
- 8-K2025-12-12 View
- 10-Q2025-11-13 View
- 8-K2025-10-09 View
- 42025-09-22 View
- 42025-09-19 View
- 42025-08-26 View
- 42025-08-26 View
- 42025-08-26 View
- 10-Q2025-08-14 View
- 8-K2025-08-14 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|